trimetazidine

  1. E

    Open TRI-ME: Trimetazidine to treat Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A double-blind, randomised, placebo-controlled efficacy trial

    TRI-ME: Trimetazidine to treat Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A double-blind, randomised, placebo-controlled efficacy trial Ethics application status: Submitted, not yet approved Description of intervention(s) / exposure 1) Intervention: Trimetazidine 2) Dose: a single...
Back
Top Bottom